1Brunett IL, Desant IS ER. Treatment of viral myocarditis caused by coxsackie virus B[J]. Am J Health Syst Pham, 2008,65 (2): 132.
2Ellis CR, Disalvo T. Myocarditis basic and ciinical aspects[J]. Car diol rev, 2007,15 (4) : 170.
3Shang Y, Zhang WL. The clinical observation of astragalus injec- tion combined with interferon-a of treatment on children with viral myocarditis[J]. Chin Mod Doct, 2008,46 (18) : 178.
4Xiao J, Shmadam, LU W, et al. Anti-inflammatory effects of eplerenone on viral myocarditis[J]. Eur J Heart Fail, 2009,11 (4) 349.
1Camporeale A,Marino F,Papageorgiou A,et al.STAT3 activity is necessary and sufficient for the development of immune-mediated myocarditis in mice and promotes progression to dilated cardiomyopathy[J] .EMBO Molecular Medicine,2013,23(4):3245-3246.
2Joly P,Janela B,Tetart F,et al.Poor benefit/risk balance of intravenous immunoglobulins in DRESS[J].Archives of dermatology,2012,148(4):543.
3Kaveri S V,Maddur M S,Hegde P,et al.Intravenous immunoglobulins in immunodeficiencies:more than mere replacement therapy[J].Clinical&Experimental Immunology,2011,164(2):2.
